Autolus Therapeutics plc
AUTL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $606,802 | $412,496 | $625,395 |
| - Cash | $86,124 | $123,825 | $95,799 | $227,380 |
| + Debt | $61,007 | $64,535 | $57,708 | $297,229 |
| Enterprise Value | – | $547,512 | $374,405 | $695,244 |
| Revenue | $21,194 | $20,923 | $8,982 | $29 |
| % Growth | 1.3% | 132.9% | 30,872.4% | – |
| Gross Profit | -$7,449 | -$3,522 | -$8,969 | -$138,275 |
| % Margin | -35.1% | -16.8% | -99.9% | -476,810.3% |
| EBITDA | -$64,703 | -$56,906 | -$55,516 | -$73,787 |
| % Margin | -305.3% | -272% | -618.1% | -254,437.9% |
| Net Income | -$79,118 | -$47,917 | -$70,161 | -$27,606 |
| % Margin | -373.3% | -229% | -781.1% | -95,193.1% |
| EPS Diluted | -0.3 | -0.18 | -0.26 | -0.1 |
| % Growth | -66.7% | 30.8% | -160% | – |
| Operating Cash Flow | -$67,899 | -$72,781 | -$75,565 | -$37,934 |
| Capital Expenditures | $15,520 | -$7,277 | -$8,243 | -$23,856 |
| Free Cash Flow | -$52,379 | -$80,058 | -$83,808 | -$61,790 |